Merck – Investorempires.com

Merck, Kelun buoyed by phase 3 results for breast cancer antibody drug conjugate

Merck posts better-than-expected results on Keytruda sales jump By Reuters

Former Merck CEO Ken Frazier on the responsibility of CEOs to uphold principles despite politics

Merck KGaA says FY profit to fall to lower half of target range By Reuters

Merck inks $22B cancer drug deal with Daiichi Sankyo

Eli Lilly, Merck top pharma picks in Barclays Q2 preview

Merck in late-stage talks to acquire Prometheus Biosciences